FDA Plan to Combat Opioid Epidemic Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
5. Brain Glucose Levels Drop in Patients with Obesity, Diabetes
Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes. Read more.
4. FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma
Calquence is a kinase inhibitor that blocks an enzyme crucial for cancer growth. Read more.
3. CVS Launches New Performance-Based PBM Network
New network encourages medication adherence for chronic conditions. Read more.
2. Novartis Seeks New Indication for Gene Therapy Kymriah
Tisagenlecleucel (Kyrmiah) shows promise as a treatment for diffuse large B-cell lymphoma. Read more.
1. FDA Highlights New Strategies to Combat the Opioid Epidemic
Novel methods to package, store, and dispose of opioids could fight the ongoing epidemic. Read more.
